Parma, Italy

Alessandro Accetta

USPTO Granted Patents = 10 

 

 

Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2016-2023

Loading Chart...
Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Alessandro Accetta

Introduction

Alessandro Accetta is a prominent inventor based in Parma, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that inhibit Rho Kinase. With a total of 10 patents to his name, Accetta's work has the potential to impact the treatment of various pulmonary diseases.

Latest Patents

Accetta's latest patents include innovative compounds that serve as Rho-Kinase inhibitors. One notable invention is the "Meta tyrosine derivatives as Rho-kinase inhibitors." This invention relates to compounds that inhibit Rho Kinase and are specifically designed to treat disorders associated with ROCK enzyme mechanisms. These compounds may be particularly useful in addressing pulmonary diseases such as asthma, chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis (IPF), and pulmonary arterial hypertension (PAH).

Another significant patent is the "Oxadiazole derivatives as Rho-Kinase Inhibitors." Similar to his previous work, this invention focuses on compounds that inhibit Rho Kinase and are designed to treat various pulmonary disorders. The therapeutic applications of these compounds highlight Accetta's commitment to advancing medical science and improving patient outcomes.

Career Highlights

Alessandro Accetta is currently employed at Chiesi Farmaceutici S.p.a., a leading pharmaceutical company. His role at Chiesi has allowed him to collaborate with other talented professionals in the field, further enhancing his contributions to pharmaceutical innovation.

Collaborations

Accetta has worked alongside notable colleagues such as Anna Maria Capelli and Fabio Rancati. Their collaborative efforts have played a crucial role in the development of groundbreaking pharmaceutical solutions.

Conclusion

Alessandro Accetta's innovative work in the field of pharmaceuticals, particularly in the development of Rho-Kinase inhibitors, showcases his dedication to improving healthcare. His contributions have the potential to significantly impact the treatment of various pulmonary diseases, making him a noteworthy figure in the realm of medical inventions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…